LunaVax

A historic national effort. Nigeria has launched Africa’s largest integrated health campaign, targeting nearly 100 million children with life-saving vaccines and treatments. From measles-rubella and HPV to polio, routine childhood vaccines, NTD interventions, and malaria SMC, this coordinated nationwide push aims to close long-standing immunity gaps across all 36 states. The campaign is rolling out

Biometrics that count. In Ghana, frontline health workers are using Simprints’ biometric technology to make sure vaccines reach the child they are meant for. By linking each patient to a unique digital identity, no dose is wasted, no record is lost, and no child is overlooked. For health systems facing challenges of duplication, misidentification, and

A first for Africa: Nigeria sustains WHO’s ML3 status. In August 2025, Nigeria became the first country in Africa to successfully sustain the World Health Organization’s Maturity Level 3 (ML3) for regulating medicines and vaccines. This milestone confirms that the country’s system is strong enough to support safe, local vaccine production, a step toward self-reliance

Needle-free. No clinic required. In Nigeria and other regions where distance and infrastructure limit access, Microneedle vaccine patches (MAPs) could bring vaccines closer to the people who need them most. MAPs are an emerging vaccine delivery method designed to be painless, easy to apply, and stable without cold-chain requirements for extended periods. Instead of requiring

20,000 vaccine deliveries. No roads required. In Bayelsa, Nigeria, malaria vaccines are now reaching hard-to-reach communities by air. A Gavi-backed initiative, in partnership with Zipline, is delivering hope—one drone drop at a time—where traditional health delivery can’t go. At LunaVax, we spotlight bold solutions advancing last-mile vaccine access. From drones today to microneedle patches tomorrow,